Industry

DUBLIN–(BUSINESS WIRE)–The “Cataract Surgery Devices Market Research Report by Product (Femtosecond Laser Equipment, Intraocular Lens, and Ophthalmic Viscoelastic Device), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Cataract Surgery Devices Market size was … [Read more…]

Sensate gives people around the world an easy solution to combating everyday stress with its patented relaxation device, revolutionizing the $4.2T wellness market. LOS ANGELES–(BUSINESS WIRE)–#HealthAndWellness–Sensate, a wellness technology company that created a patented relaxation device turning the tide on stress, launched a community investment round on Wefunder. The venture-backed company is choosing to invite … [Read more…]

Urovant Sciences, Inc. receives Fortune and Great Place to Work Best Workplaces in BioPharma (2022) recognition. Follows Urovant’s Best Place to Work recognition by the Orange County Business Journal for the second year in a row, along with becoming a Great Place to Work-Certified™ company earlier this year. The Best Workplaces in BioPharma award is … [Read more…]

Only solution of its kind in the ambulatory setting offers information on localized antibiotic susceptibility patterns and associated drug information WATERTOWN, Mass.–(BUSINESS WIRE)–epocrates, an athenahealth, Inc. company that delivers digital clinical decision support to healthcare professionals, today announced the release of Bugs + Drugs, a mobile tool that offers clinicians information about bacteria types and … [Read more…]

Approximately $600 Million of Incremental Liquidity Expected, Inclusive of Proceeds from Anticipated Springstone Operating Loan Repayment Transactions Highlight Enduring Demand for Essential Hospital Real Estate BIRMINGHAM, Ala.–(BUSINESS WIRE)–Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced that it has successfully re-leased its Watsonville Community Hospital in Watsonville, CA to Pajaro Valley Health … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene Corporation today announced a Master Agreement with Massachusetts General Hospital Cancer Center, a member of the Mass General Brigham (MGB) healthcare system, to collaborate on multiple research projects. The alliance aims to support clinical research utilizing BostonGene’s CLIA-certified and CAP-accredited high complexity molecular laboratory and advanced computational algorithms to identify and validate … [Read more…]

Company Innovators to Lead Sessions on Regulatory Affairs, Imaging, Risk-Based Quality Management, and Medidata Clinical Cloud Technology NEW YORK–(BUSINESS WIRE)–Experts from Medidata, a Dassault Systèmes company, will be chairing sessions on promoting consensus between regulators and the industry, imaging quality control, and presenting a product showcase on Medidata Clinical Cloud at the Society for Clinical … [Read more…]

Study Evaluates the Effectiveness of TherOx Supersaturated Oxygen (SSO2) Therapy in Patients Presenting with Acute Anterior Myocardial Infarction with Successful Reperfusion Compared to Standard Therapy CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the first patient has enrolled in the AMIHOT III post-approval … [Read more…]

REIMS, France–(BUSINESS WIRE)–BCV announces a major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment – the GECKO System. The first-in-human case was conducted by Michel Piotin, MD, PhD, head of Interventional neuroradiology at Foundation Rothschild Hospital in Paris, France. Worldwide each year more than 12.2 million people suffer a stroke.1 … [Read more…]

New capital will support ongoing development of their drug pipeline targeting transcriptional mechanisms in disease Arpeggio’s technology isolates a drug’s effect on entire transcriptomes and has identified new modulators of hard-to-drug proteins like transcription factors To date, Arpeggio has contracted with more than 40 pharmaceutical companies to assess the impact of diverse classes of molecules … [Read more…]